R.S. IPRATROP 1.25 

Levosalbutamol & Ipratropium Bromide Respiratory Solution

R.S. IPRATROP 1.25 is a respiratory solution comprising Levosalbutamol and Ipratropium Bromide. This combination medication is used to treat and manage chronic obstructive pulmonary disease (COPD) and asthma. COPD is a long-term condition that causes inflammation and damage to the lungs, making breathing difficult. Asthma, on the other hand, is characterized by recurring episodes of airway narrowing and inflammation. 

Composition

• Levosalbutamol: 1.25 mg
• Ipratropium Bromide: 0.5 mg

Mechanism of Action

Levosalbutamol

Levosalbutamol is a selective beta2-adrenergic receptor agonist. It works by stimulating the beta2 receptors in the bronchial muscles, leading to muscle relaxation.Levosalbutamol is known for its rapid onset of action, providing quick relief from bronchospasm.

Ipratropium Bromide

Ipratropium Bromide is an anticholinergic agent that works by inhibiting the muscarinic receptors in the bronchial smooth muscle. This inhibition prevents the bronchoconstriction (narrowing of the airways) that is typically induced by acetylcholine, a neurotransmitter. By blocking these receptors, Ipratropium Bromide helps to keep the airways open, facilitating smoother and easier breathing.

Indications

R.S. IPRATROP 1.25 is indicated for:

• Management of chronic obstructive pulmonary disease (COPD)
• Relief of acute bronchospasm in asthma
• Prevention of bronchospasm induced by exercise or allergens
• Improvement of lung function in patients with obstructive airway diseases

Dosage and Administration

The dosage of R.S. IPRATROP 1.25 should be individualized based on the severity of the condition and the response to the medication. It is typically administered via a nebulizer.

• For adults and children above 12 years: One ampoule (containing 1.25 mg of Levosalbutamol and 0.5 mg of Ipratropium Bromide) nebulized 3 to 4 times a day.
• For children under 12 years: The dosage should be adjusted by a healthcare professional according to the child’s specific needs.

Side Effects

While R.S. IPRATROP 1.25 is generally well-tolerated, some individuals may experience side effects. These side effects can be mild or severe and may require medical attention.

Common Side Effects

• Tremors
• Headache
• Dry mouth
• Cough
• Nausea
• Dizziness

Serious Side Effects

• Chest pain
• Rapid or irregular heartbeat
• Severe bronchospasm

Precautions and Warnings

• Allergy: Patients with known hypersensitivity to Levosalbutamol, Ipratropium Bromide, or any other component of the formulation should avoid using this medication.
• Heart Conditions: Use with caution in patients with cardiovascular disorders, including hypertension, arrhythmias, and coronary artery disease.
• Glaucoma: Patients with narrow-angle glaucoma should use this medication cautiously as it can increase intraocular pressure.
• Prostatic Hyperplasia: Patients with prostatic hyperplasia or bladder neck obstruction should be monitored as Ipratropium Bromide may worsen urinary retention.

Drug Interactions

• Beta-blockers: Concurrent use with beta-blockers may reduce the efficacy of Levosalbutamol.
• Diuretics: Potassium-depleting diuretics may enhance the hypokalemic effect of Levosalbutamol.
• Other Anticholinergics: Combined use with other anticholinergic drugs may increase the risk of side effects.

Storage

Store R.S. IPRATROP 1.25 in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

The price of R.S. IPRATROP 1.25 can vary based on the region and the pharmacy. 

Conclusion

R.S. IPRATROP 1.25 is an effective respiratory solution that combines Levosalbutamol and Ipratropium Bromide to provide relief from bronchospasm in conditions like COPD and asthma. By targeting both beta2 receptors and muscarinic receptors, this medication ensures a comprehensive approach to managing obstructive airway diseases. Proper usage, adherence to dosage instructions, and awareness of potential side effects are crucial for achieving optimal therapeutic outcomes. Always consult a healthcare professional before starting or adjusting the treatment regimen to ensure it aligns with individual health needs.

Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology

For further information

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488

BUY NOW